Page last updated: 2024-11-07

estrone-3-o-sulfamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

estrone-3-O-sulfamate: a steroid sulfatase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127676
CHEMBL ID122708
SCHEMBL ID305660
MeSH IDM0234863

Synonyms (29)

Synonym
nsc-685426
NCI60_030717
emate
estrone-3-o-sulfamate
emate compound
3-((aminosulfonyl)oxy)estra-1,3,5(10)-trien-17-one
estra-1,3,5(10)-trien-17-one, 3-((aminosulfonyl)oxy)-
estra-1,3,5(10)-trien-17-one-3-sulfamate
oestrone-3-o-sulphamate
bdbm50134329
estrone3-o-sulfamate
sulfamic acid (8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-yl ester
sulfamic acid (11r,12s,15s,16s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-yl ester
estra-1,3,5(10)-trien-17-one-3-sulphamate
CHEMBL122708 ,
148672-09-7
[(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] sulfamate
estrone o-sulfamate
estrone 3-o-sulfamate
3-[(aminosulfonyl)oxy]estra-1,3,5(10)-trien-17-one
SCHEMBL305660
17-oxoestra-1,3,5(10)-trien-3-yl sulfamate
RVKFQAJIXCZXQY-CBZIJGRNSA-N
17-oxoestra-1,3,5(10)-triene-3-yl sulfamate
AKOS030241107
J-008505
DTXSID20933447
HY-14585
CS-0003462

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The clearance of EMATE from plasma followed a bi-phasic curve, showing an initial half-life of 30 min, followed by a slower half-life of 4 h 30 min."( Pharmacokinetics of oestrone-3-O-sulphamate.
Hidalgo Aragones, MI; Parish, D; Potter, BV; Pouton, CW; Purohit, A; Reed, MJ; Sahm, UG, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (11)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 1Homo sapiens (human)IC50 (µMol)0.03700.00582.14107.9000AID50344
Carbonic anhydrase 1Homo sapiens (human)Ki3.09530.00001.372610.0000AID257062; AID47709; AID50365; AID644084
Carbonic anhydrase 2Homo sapiens (human)IC50 (µMol)0.02800.00021.10608.3000AID1249494; AID275898; AID461822; AID47745; AID47748
Carbonic anhydrase 2Homo sapiens (human)Ki0.04670.00000.72369.9200AID254247; AID257063; AID47930; AID48092; AID644085
Tubulin alpha-1A chainSus scrofa (pig)IC50 (µMol)25.90000.00672.160310.0000AID1865677
Tubulin beta chainSus scrofa (pig)IC50 (µMol)25.90000.00672.137410.0000AID1865677
Steryl-sulfataseHomo sapiens (human)IC50 (µMol)0.75380.00010.40717.6000AID1243900; AID1299642; AID1299647; AID1299653; AID1299666; AID1299668; AID1299670; AID1299672; AID1438381; AID1600012; AID1600037; AID1667478; AID1903876; AID205639; AID205754; AID205757; AID205758; AID205762; AID205766; AID205768; AID205769; AID205770; AID240903; AID241447; AID241450; AID241794; AID248500; AID623099; AID654844; AID654845; AID70816; AID70818; AID70819; AID70824; AID70848; AID70849; AID70851; AID70852; AID70853; AID70854; AID70855; AID71010; AID91648
Steryl-sulfataseHomo sapiens (human)Ki0.62000.47000.62000.6700AID205779; AID205780; AID238668; AID238712
Carbonic anhydrase 4Homo sapiens (human)Ki1.04000.00021.97209.9200AID644086
Carbonic anhydrase 6Homo sapiens (human)Ki1.86000.00011.47109.9200AID644087
Carbonic anhydrase 9Homo sapiens (human)Ki0.03000.00010.78749.9000AID254248; AID257065; AID48298; AID48305
Carbonic anhydrase 3Bos taurus (cattle)Ki12.42000.11303.88159.7100AID644088
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Estrogen receptorHomo sapiens (human)EC50 (µMol)2.60000.00000.53054.4000AID69861
Estrogen receptor betaHomo sapiens (human)EC50 (µMol)3.70000.00000.47954.8900AID70019
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Estrogen receptorHomo sapiens (human)ED502.60000.05101.32552.6000AID70193
Steryl-sulfataseHomo sapiens (human)Km95.00000.80001.25001.7000AID205787
Estrogen receptor betaHomo sapiens (human)ED503.70000.07001.88503.7000AID70509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (64)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
antral ovarian follicle growthEstrogen receptorHomo sapiens (human)
epithelial cell developmentEstrogen receptorHomo sapiens (human)
chromatin remodelingEstrogen receptorHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
signal transductionEstrogen receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEstrogen receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEstrogen receptorHomo sapiens (human)
androgen metabolic processEstrogen receptorHomo sapiens (human)
male gonad developmentEstrogen receptorHomo sapiens (human)
negative regulation of gene expressionEstrogen receptorHomo sapiens (human)
positive regulation of phospholipase C activityEstrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayEstrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptorHomo sapiens (human)
response to estradiolEstrogen receptorHomo sapiens (human)
regulation of toll-like receptor signaling pathwayEstrogen receptorHomo sapiens (human)
negative regulation of smooth muscle cell apoptotic processEstrogen receptorHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionEstrogen receptorHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
response to estrogenEstrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
fibroblast proliferationEstrogen receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEstrogen receptorHomo sapiens (human)
stem cell differentiationEstrogen receptorHomo sapiens (human)
regulation of inflammatory responseEstrogen receptorHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
RNA polymerase II preinitiation complex assemblyEstrogen receptorHomo sapiens (human)
uterus developmentEstrogen receptorHomo sapiens (human)
vagina developmentEstrogen receptorHomo sapiens (human)
prostate epithelial cord elongationEstrogen receptorHomo sapiens (human)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisEstrogen receptorHomo sapiens (human)
regulation of branching involved in prostate gland morphogenesisEstrogen receptorHomo sapiens (human)
mammary gland branching involved in pregnancyEstrogen receptorHomo sapiens (human)
mammary gland alveolus developmentEstrogen receptorHomo sapiens (human)
epithelial cell proliferation involved in mammary gland duct elongationEstrogen receptorHomo sapiens (human)
protein localization to chromatinEstrogen receptorHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptorHomo sapiens (human)
negative regulation of miRNA transcriptionEstrogen receptorHomo sapiens (human)
regulation of epithelial cell apoptotic processEstrogen receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptorHomo sapiens (human)
steroid catabolic processSteryl-sulfataseHomo sapiens (human)
female pregnancySteryl-sulfataseHomo sapiens (human)
epidermis developmentSteryl-sulfataseHomo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 6Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
signal transductionEstrogen receptor betaHomo sapiens (human)
cell-cell signalingEstrogen receptor betaHomo sapiens (human)
negative regulation of cell growthEstrogen receptor betaHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptor betaHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptor betaHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
TFIIB-class transcription factor bindingEstrogen receptorHomo sapiens (human)
transcription coregulator bindingEstrogen receptorHomo sapiens (human)
transcription corepressor bindingEstrogen receptorHomo sapiens (human)
transcription coactivator bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
chromatin bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
nuclear receptor activityEstrogen receptorHomo sapiens (human)
steroid bindingEstrogen receptorHomo sapiens (human)
protein bindingEstrogen receptorHomo sapiens (human)
calmodulin bindingEstrogen receptorHomo sapiens (human)
beta-catenin bindingEstrogen receptorHomo sapiens (human)
zinc ion bindingEstrogen receptorHomo sapiens (human)
TBP-class protein bindingEstrogen receptorHomo sapiens (human)
enzyme bindingEstrogen receptorHomo sapiens (human)
protein kinase bindingEstrogen receptorHomo sapiens (human)
nitric-oxide synthase regulator activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor bindingEstrogen receptorHomo sapiens (human)
estrogen response element bindingEstrogen receptorHomo sapiens (human)
identical protein bindingEstrogen receptorHomo sapiens (human)
ATPase bindingEstrogen receptorHomo sapiens (human)
14-3-3 protein bindingEstrogen receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingEstrogen receptorHomo sapiens (human)
steryl-sulfatase activitySteryl-sulfataseHomo sapiens (human)
sulfuric ester hydrolase activitySteryl-sulfataseHomo sapiens (human)
metal ion bindingSteryl-sulfataseHomo sapiens (human)
arylsulfatase activitySteryl-sulfataseHomo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Bos taurus (cattle)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptor betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptor betaHomo sapiens (human)
DNA bindingEstrogen receptor betaHomo sapiens (human)
nuclear steroid receptor activityEstrogen receptor betaHomo sapiens (human)
nuclear receptor activityEstrogen receptor betaHomo sapiens (human)
steroid bindingEstrogen receptor betaHomo sapiens (human)
protein bindingEstrogen receptor betaHomo sapiens (human)
zinc ion bindingEstrogen receptor betaHomo sapiens (human)
enzyme bindingEstrogen receptor betaHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptor betaHomo sapiens (human)
estrogen response element bindingEstrogen receptor betaHomo sapiens (human)
receptor antagonist activityEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (36)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
nucleoplasmEstrogen receptorHomo sapiens (human)
transcription regulator complexEstrogen receptorHomo sapiens (human)
cytoplasmEstrogen receptorHomo sapiens (human)
Golgi apparatusEstrogen receptorHomo sapiens (human)
cytosolEstrogen receptorHomo sapiens (human)
plasma membraneEstrogen receptorHomo sapiens (human)
membraneEstrogen receptorHomo sapiens (human)
chromatinEstrogen receptorHomo sapiens (human)
euchromatinEstrogen receptorHomo sapiens (human)
protein-containing complexEstrogen receptorHomo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
lysosomeSteryl-sulfataseHomo sapiens (human)
endosomeSteryl-sulfataseHomo sapiens (human)
endoplasmic reticulumSteryl-sulfataseHomo sapiens (human)
endoplasmic reticulum lumenSteryl-sulfataseHomo sapiens (human)
endoplasmic reticulum membraneSteryl-sulfataseHomo sapiens (human)
Golgi apparatusSteryl-sulfataseHomo sapiens (human)
plasma membraneSteryl-sulfataseHomo sapiens (human)
membraneSteryl-sulfataseHomo sapiens (human)
intracellular membrane-bounded organelleSteryl-sulfataseHomo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
extracellular regionCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
cytosolCarbonic anhydrase 6Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
nucleoplasmEstrogen receptor betaHomo sapiens (human)
mitochondrionEstrogen receptor betaHomo sapiens (human)
intracellular membrane-bounded organelleEstrogen receptor betaHomo sapiens (human)
chromatinEstrogen receptor betaHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (146)

Assay IDTitleYearJournalArticle
AID70994Compound was tested for the Inhibitory activity against the Estrone Sulfatase at a concentration of 50 uM; ND means not determined2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID69861Affinity for human estrogen receptor alpha2003Bioorganic & medicinal chemistry letters, Dec-15, Volume: 13, Issue:24
6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
AID47930Inhibition against human carbonic anhydrase II2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase.
AID205795Tested for relative inhibitory potency against recombinant human steroid sulfatase2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New fluorogenic substrate for the first continuous steroid sulfatase assay.
AID654851Inhibition of steroid sulfatase in rat liver at 10 mg/kg, sc administered as single dose measured up to 7 days2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID1865674Antiproliferative activity against human MKN-45 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID1865676Inhibition of Arylsulfatase (unknown origin) using potassium p-nitrophenyl sulfate as substrate incubated for 5 mins2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID70819In vitro inhibition of estrone sulfatase in placental microsomes1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
AID47745Compound was tested for inhibition of human carbonic anhydrase (hCA II)2003Bioorganic & medicinal chemistry letters, Mar-10, Volume: 13, Issue:5
Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II.
AID205757Inhibition of steroid sulfatase activity by the compound was determined in human embryonic kidney (HEK)-293 cells transfected with a sulfatase expression vector (pCMV-sulfa) using 100 uM of [3H]E1S2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
AID654849Inhibition of steroid sulfatase in rat liver at 10 mg/kg, sc2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID70193Affinity of sulfamate compound for human estrogen receptor alpha2003Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID47709Inhibition of human recombinant carbonic anhydrase I2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
AID50344Inhibitory activity of compound against human carbonic anhydrase I2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride.
AID654844Inhibition of steroid sulfatase in human placental microsomes using [3H]E1S as substrate after 30 mins by scintillation spectrometry2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID70833Tested for inhibition of estrone sulfatase in MCF-7 breast cancer cells using 2 nM substrate concentration at 10 uM1994Journal of medicinal chemistry, Jan-21, Volume: 37, Issue:2
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
AID70844In vivo inhibition of estrone sulfatase in rat liver after oral administration1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
AID1249480Invivo inhibition of steroid sulfatase activity in rat liver at 10 mg/kg, po measured after 2 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID1249481Invivo inhibition of steroid sulfatase activity in rat liver at 20 mg/kg, po measured after 2 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID70854Inhibitory concentration required to inhibit the enzyme estrone sulfatase was determined2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
AID291824Inhibition of Estrone sulfatase in human placental microsome2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase.
AID254248Inhibition of catalytic domain of human recombinant carbonic anhydrase IX2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II.
AID1299672Inhibition of human placental microsomal estrone sulfatase using 4-methylumbelliferyl sulfate as substrate incubated for 1 hr by fluorescence assay2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID257064Inhibition of recombinant human mitochondrial isozyme CA VA2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
AID70839Estrogenic potency against Estrone sulfatase (E1-STS) was determined in vivo by administering to rats1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
AID1299668Inhibition of estrone sulfatase in human JEG-3 cells using [3H]-estrone sulphate as substrate incubated for 4 hrs by liquid scintillation counting method2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID1249487Inhibition of STS (unknown origin) at 1 uM2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID103895Anti-proliferative activity against MCF-7 human breast cancer cells was determined by using MCF-7 plate assay2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents.
AID70852Inhibitory concentration against estrone sulfatase2001Bioorganic & medicinal chemistry letters, Apr-09, Volume: 11, Issue:7
Acid dissociation constant, a potential physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
AID205782Rate constant of inactivation against human steroid sulfatase2003Bioorganic & medicinal chemistry letters, Dec-15, Volume: 13, Issue:24
6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
AID1865675Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID19447Partition coefficient (logP)2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID55980In vivo inhibition against dehydroepiandrosterone sulfatase (DHA-STS) in rat liver.1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
AID1600013In vivo inhibition of liver steroid sulfatase in Wistar rat at 0.1 mg/kg relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
AID1865672Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID102630Stimulation of MCF-7 cell proliferation at 1000 nM2003Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID26792Partition coefficient (logP)2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
AID102628Stimulation of MCF-7 cell proliferation at 100 nM2003Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID26348pKa value was determined2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID654845Inhibition of steroid sulfatase in human MCF7 cells using [3H]E1S as substrate after 20 hrs by scintillation spectrometry2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID70851Inhibition of Estrone sulfatase2001Bioorganic & medicinal chemistry letters, Mar-26, Volume: 11, Issue:6
Novel inhibitors of the enzyme estrone sulfatase (ES).
AID70838Inhibition of estrone sulfatase in MCF-7 breast cancer cells at 0.1 uM1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
AID1865670Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID48298Inhibition against human carbonic anhydrase IX2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase.
AID1865671Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID238668Inhibitory activity against human steroid sulfatase2004Journal of medicinal chemistry, Aug-12, Volume: 47, Issue:17
2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase.
AID70829Tested for enzyme inhibition after 20h in MCF-7 breast cancer cells at 1 uM; NA=No activity1994Journal of medicinal chemistry, Jan-21, Volume: 37, Issue:2
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
AID1299647Inhibition of estrone sulfatase (unknown origin) transfected in HEK293 cells using [3H]E1S as substrate incubated for 2 hrs by liquid scintillation counting method2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID205766Inhibitory activity against purified human Steroid sulfatase2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase.
AID48305Inhibitory concentration against catalytic domain of human cloned carbonic anhydrase IX.2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
AID205770Inhibitory activity against steroid sulfatase enzyme2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents.
AID1249553Invivo inhibition of steroid sulfatase activity in human assessed as decrease in DHEA level after 72 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID47748Inhibitory activity of compound against human carbonic anhydrase II2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride.
AID1249484Invivo inhibition of steroid sulfatase activity in rat WBC at 20 mg/kg, po measured after 2 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID241794Inhibitory concentration against human steroid sulfatase expressed in CHO cells2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase.
AID1438381Inhibition of STS in human MCF7 cells2017European journal of medicinal chemistry, Mar-10, Volume: 128Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
AID1337728Inhibition of recombinant human CYP1B1 expressed in bacterial microsomes co-expressing P450 reductase at 3 uM using 7-ethyl-O-resorufin as substrate after 45 mins in presence of NADPH by fluorescence assay relative to control2016Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives.
AID70019Affinity for human estrogen receptor beta2003Bioorganic & medicinal chemistry letters, Dec-15, Volume: 13, Issue:24
6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
AID654850Inhibition of steroid sulfatase in rat liver at 10 mg/kg, po administered as single dose measured up to 7 days2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID48113Inhibitory activity of compound against bovine carbonic anhydrase IV; not tested2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride.
AID70816Tested for the inhibitory activity against Estrone Sulfatase2001Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
Determination and use of a transition state for the enzyme estrone sulfatase (ES) from a proposed reaction mechanism.
AID1249485Invivo inhibition of steroid sulfatase activity in rat WBC at 40 mg/kg, po measured after 2 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID1249555Invivo inhibition of steroid sulfatase activity in human assessed as decrease in DHEAS level after 72 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID248500Inhibitory activity against human steroid sulfatase over-expressed in CHO cells2004Journal of medicinal chemistry, Aug-12, Volume: 47, Issue:17
2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase.
AID70848Inhibitory activity against estrone sulfatase enzyme1999Bioorganic & medicinal chemistry letters, Jun-21, Volume: 9, Issue:12
Derivation of a possible transition-state for the reaction catalysed by the enzyme estrone Sulfatase (ES).
AID275898Inhibition of human CA22006Journal of medicinal chemistry, Dec-28, Volume: 49, Issue:26
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.
AID70509Affinity of sulfamate compound for human estrogen receptor beta2003Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID70840In vivo inhibition against Estrone sulfatase (E1-STS) in rat liver.1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
AID461822Inhibition of human CA2 by colorimetric assay2010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
AID1299670Inhibition of human placental microsomal estrone sulfatase using [3H]E1S as substrate incubated for 20 mins by scintillation counting method2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID205762Inhibitory activity against Steroid sulfatase expressed in CHO cells2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase.
AID1243900Inhibition of STS in human MCF7 cells2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis of bicoumarin thiophosphate derivatives as steroid sulfatase inhibitors.
AID1299642Inhibition of placental microsomal estrone sulfatase (unknown origin) using [6,7-3H]E1S as substrate incubated for 1 hr by scintillation spectrometric analysis2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID205769Inhibition of steroid sulfatase2003Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID1249554Invivo inhibition of steroid sulfatase activity in human assessed as decrease in DHEAS level after 24 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID654848Inhibition of steroid sulfatase in rat liver at 10 mg/kg, po2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID70849Inhibitory activity against Estrone Sulfatase2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID71010Inhibition of estrone sulfatase2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID1249479Invivo inhibition of steroid sulfatase activity in Wistar rat liver assessed as inhibition of dehydroepiandrosterone sulfate hydrolysis at 0.1 mg/kg, sc for 7 days2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID19659Partition coefficient (logP)2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
AID70831Tested for inhibition of estrone sulfatase in MCF-7 breast cancer cells using 2 nM substrate concentration at 1 uM1994Journal of medicinal chemistry, Jan-21, Volume: 37, Issue:2
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
AID240903Inhibition of purified human steroid sulfatase2004Bioorganic & medicinal chemistry letters, Oct-04, Volume: 14, Issue:19
Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
AID71012Inhibitory activity against estrone sulfatase at 10 uM (initial screening)2004Bioorganic & medicinal chemistry letters, Feb-09, Volume: 14, Issue:3
Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID190399Effect on uterine weight gain in ovariectomized rat, expressed as uterine weight/total body weight X100 (0.036+/-0.001)1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
AID1249482Invivo inhibition of steroid sulfatase activity in rat liver at 40 mg/kg, po measured after 2 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID70837Inhibitory activity against Estrone sulfatase (E1-STS) in MCF-7 breast cancer cells at 0.1 uM1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
AID70824Tested for inhibition of estrone sulfatase in placental microsomal preparation (100000 g pellet) using substrate concentration of 20 uM1994Journal of medicinal chemistry, Jan-21, Volume: 37, Issue:2
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
AID205779Inhibitory constant against human steroid sulfatase in CHO cells2003Bioorganic & medicinal chemistry letters, Dec-15, Volume: 13, Issue:24
6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
AID1249494Inhibition of human carbonic anhydrase 22015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID70857Compound was evaluated for its percent inhibition against the enzyme estrone sulfatase2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
AID1299666Inhibition of human placental estrone sulfatase expressed in HEK293 cells using [3H]E1S as substrate incubated for 2 hrs by liquid scintillation counting method2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID1249476Inhibition of STS activity in human MCF7 cells at 0.1 uM2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID644086Inhibition of human carbonic anhydrase 4 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis2012European journal of medicinal chemistry, Mar, Volume: 49Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.
AID205754Compound was tested for its ability to inhibit the transformation of [C14]-DHEAS to DHEA by steroid sulfatase derived from human embryonal kidney cell1999Journal of medicinal chemistry, Jun-17, Volume: 42, Issue:12
Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
AID70830Tested for inhibition of estrone sulfatase in MCF-7 breast cancer cells using 2 nM substrate concentration at 0.1 uM1994Journal of medicinal chemistry, Jan-21, Volume: 37, Issue:2
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
AID257065Inhibition of cloned human transmembrane, tumor-associated isozyme CA IX2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
AID1600037Inhibition of human placental steroid sulfatase expressed in HEK293 cells using [3H] E1S as substrate after 2 hrs by liquid scintillation counting method2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
AID238712Inhibitory constant against human steroid sulfatase2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase.
AID71005Relative potency compared to COUMATE against Estrone sulfatase2001Bioorganic & medicinal chemistry letters, Mar-26, Volume: 11, Issue:6
Novel inhibitors of the enzyme estrone sulfatase (ES).
AID623099Inhibition of human purified steroid sulfatase2011Bioorganic & medicinal chemistry, Oct-15, Volume: 19, Issue:20
Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
AID644084Inhibition of human carbonic anhydrase 1 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis2012European journal of medicinal chemistry, Mar, Volume: 49Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.
AID70999Inhibitory activity against estrone sulfatase expressed as potency2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
AID70818Inhibitory activity againist Estrone sulfatase from MCF-7 cells (placental microsomes)2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
A novel type of nonsteroidal estrone sulfatase inhibitors.
AID1249478Invivo inhibition of steroid sulfatase activity in Wistar rat liver assessed as inhibition of estrone sulfate hydrolysis at 0.1 mg/kg, sc for 7 days2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID257063Inhibition of recombinant human cytosolic isozyme CA II2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
AID1600011Inhibition of steroid sulfatase (unknown origin) at 0.1 uM relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
AID1865673Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID205758Inhibition of steroid sulfatase activity by the compound was determined in human embryonic kidney (HEK)-293 cells transfected with a sulfatase expression vector (pCMV-sulfa) using 100 uM of [14C]-DHEAS2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
AID644088Inhibition of bovine carbonic anhydrase 3 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis2012European journal of medicinal chemistry, Mar, Volume: 49Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.
AID70998In vitro inhibition of estrone sulfatase at 1 mM.2002Bioorganic & medicinal chemistry letters, May-06, Volume: 12, Issue:9
The mechanism of the irreversible inhibition of estrone sulfatase (ES) through the consideration of a range of methane- and amino-sulfonate-based compounds.
AID71000Inhibitory activity against estrone sulfatase relative to 4-Methylcoumarin-7-O-sulfamate derivative (COUMATE)2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
AID70847Compound was evaluated for its inhibitory activity against estrone sulfatase enzyme2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
AID1903876Inhibition of STS in human MCF7 cells assessed as reduction in [3H]estradiol and [3H]estrone formation using [3H]estrone sulfate as substrate incubated for 20 hrs2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Development of Sulfamoylated 4-(1-Phenyl-1
AID1600015In vivo inhibition of steroid sulfatase in Wistar rat assessed as enzyme recovery at 10 mg/kg, sc single dose treated for 10 days measured after 15 days relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
AID1600012Inhibition of steroid sulfatase (unknown origin)2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
AID19203Calculated partition coefficient (clogP)2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID71003Relative potency against Estrone sulfatase2001Bioorganic & medicinal chemistry letters, Mar-26, Volume: 11, Issue:6
Novel inhibitors of the enzyme estrone sulfatase (ES).
AID1249552Invivo inhibition of steroid sulfatase activity in human assessed as decrease in DHEA level after 12 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID1299653Inhibition of placental microsomal estrone sulfatase (unknown origin) using [3H]-estrone sulphate as substrate2016European journal of medicinal chemistry, May-23, Volume: 114Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
AID654852Inhibition of steroid sulfatase in human placental microsomes2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
AID1249492Inhibition of STS activity in human placental microsome2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID1667478Reversible inhibition of steroid sulfatase in human JEG3 cells using [3H] E1S as substrate by scintillation counting method2020Bioorganic & medicinal chemistry, 04-01, Volume: 28, Issue:7
Design and synthesis of dansyl-labeled inhibitors of steroid sulfatase for optical imaging.
AID254247Inhibition of cloned human carbonic anhydrase II2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II.
AID1249500Growth inhibition of human MCF7 cells2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID644087Inhibition of human carbonic anhydrase 6 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis2012European journal of medicinal chemistry, Mar, Volume: 49Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.
AID205787Tested for inhibitory potency against recombinant human steroid sulfatase2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New fluorogenic substrate for the first continuous steroid sulfatase assay.
AID257062Inhibition of recombinant human cytosolic isozyme CA I2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
AID205768Inhibitory activity against purified human steroid sulfatase (STS)2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID70991Compound was tested for the Inhibitory activity against the Estrone Sulfatase at a concentration of 10 uM2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
AID644085Inhibition of human carbonic anhydrase 2 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis2012European journal of medicinal chemistry, Mar, Volume: 49Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.
AID102627Stimulation of MCF-7 cell proliferation at 10 nM2003Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
AID1895185Inhibition of lysosome sulfatase (unknown origin) assessed as reduction in fluorescence intensity using 2-(2-Morpholinoethyl)-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1H-benzo[de]-isoquinoline-1,3(2H)-dione as s2021Journal of medicinal chemistry, 06-24, Volume: 64, Issue:12
New Protocol-Guided Exploitation of a Lysosomal Sulfatase Inhibitor to Suppress Cell Growth in Glioblastoma Multiforme.
AID70853Inhibition of estrone sulfatase (ES)2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
AID234881Potency for the inhibition of estrone sulfatase relative to coumate2001Bioorganic & medicinal chemistry letters, Apr-09, Volume: 11, Issue:7
Acid dissociation constant, a potential physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
AID241447Inhibitory concentration against steroid sulfatase in placental microsomes2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
AID1600016In vivo inhibition of steroid sulfatase in rat at 10 to 40 mg/kg, po relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
AID48092Inhibition of human carbonic anhydrase II2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
AID1249483Invivo inhibition of steroid sulfatase activity in rat WBC at 10 mg/kg, po measured after 2 hrs2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
AID241450Inhibitory concentration against human steroid sulfatase2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase.
AID91648Inhibition of human steroid sulfatase compared to EMATE2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase.
AID1865677Inhibition of pig brain tubulin polymerization by spectrophotometric method2021RSC medicinal chemistry, Aug-18, Volume: 12, Issue:8
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
AID205780Inhibitory constant against purified human Steroid sulfatase2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase.
AID70855In vitro inhibition of estrone sulfatase.2002Bioorganic & medicinal chemistry letters, May-06, Volume: 12, Issue:9
The mechanism of the irreversible inhibition of estrone sulfatase (ES) through the consideration of a range of methane- and amino-sulfonate-based compounds.
AID205639Compound was tested for its ability to inhibit human embryonal kidney cell derived steroid sulfatase activity in transforming [3H]E1S (estrone sulfate) to E11999Journal of medicinal chemistry, Jun-17, Volume: 42, Issue:12
Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
AID50365Inhibition against human carbonic anhydrase I2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase.
AID1600014In vivo inhibition of steroid sulfatase in Wistar rat assessed as enzyme recovery at 10 mg/kg, sc single dose treated for 3 days measured after 1 week relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (88)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's18 (20.45)18.2507
2000's52 (59.09)29.6817
2010's14 (15.91)24.3611
2020's4 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.06 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (6.74%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other83 (93.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]